SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 162 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2016. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $30,609,000 | +23.7% | 5,026,056 | +11.9% | 0.01% | +25.0% |
| Q3 2016 | $24,745,000 | +76.6% | 4,490,938 | +21.8% | 0.00% | +100.0% |
| Q2 2016 | $14,009,000 | +95.7% | 3,686,556 | +42.2% | 0.00% | +100.0% |
| Q1 2016 | $7,158,000 | -51.2% | 2,593,319 | +0.3% | 0.00% | -50.0% |
| Q4 2015 | $14,654,000 | +10.9% | 2,584,484 | +3.6% | 0.00% | 0.0% |
| Q3 2015 | $13,219,000 | -20.8% | 2,494,076 | +24.0% | 0.00% | -33.3% |
| Q2 2015 | $16,697,000 | +83.8% | 2,011,661 | +2.3% | 0.00% | +200.0% |
| Q1 2015 | $9,085,000 | +137.8% | 1,966,535 | +57.0% | 0.00% | 0.0% |
| Q4 2014 | $3,821,000 | +22.4% | 1,252,783 | +11.7% | 0.00% | 0.0% |
| Q3 2014 | $3,123,000 | -33.1% | 1,121,331 | -2.2% | 0.00% | 0.0% |
| Q2 2014 | $4,665,000 | -14.6% | 1,146,274 | +11.5% | 0.00% | 0.0% |
| Q1 2014 | $5,460,000 | -6.0% | 1,028,245 | -0.3% | 0.00% | 0.0% |
| Q4 2013 | $5,809,000 | +18.3% | 1,031,749 | -4.0% | 0.00% | 0.0% |
| Q3 2013 | $4,911,000 | +13.2% | 1,074,550 | +7.0% | 0.00% | 0.0% |
| Q2 2013 | $4,340,000 | – | 1,004,559 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,009,984 | $16,683,000 | 6.50% |
| DAFNA Capital Management LLC | 317,563 | $2,636,000 | 2.23% |
| Trellus Management Company, LLC | 162,900 | $1,352,000 | 1.53% |
| PURA VIDA INVESTMENTS, LLC | 246,250 | $2,246,000 | 1.15% |
| WALL STREET ASSOCIATES | 861,200 | $7,148,000 | 0.67% |
| EAM Investors, LLC | 670,346 | $5,564,000 | 0.65% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 200,000 | $1,660,000 | 0.58% |
| CARL DOMINO INC | 66,900 | $555,000 | 0.38% |
| Belmont Global Advisors, Inc. | 36,200 | $300,000 | 0.33% |
| Lombard Odier Asset Management (USA) Corp | 507,223 | $4,210,000 | 0.30% |